← Back to Discover
Squadron Capital Management LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $322,245,820
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- RELMADA THERAPEUTICS INC · COM · 75955J402 · shares: $50,862,000
- C4 THERAPEUTICS INC · COM STK · 12529R107 · shares: $33,624,000
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $33,475,500
- KODIAK SCIENCES INC · COM · 50015M109 · shares: $19,480,000
- RELAY THERAPEUTICS INC · COM · 75943R102 · shares: $18,148,700
- ZENTALIS PHARMACEUTICALS INC · COM · 98943L107 · shares: $17,945,000
- EDGEWISE THERAPEUTICS INC · COM · 28036F105 · shares: $11,782,700
- MAZE THERAPEUTICS INC · COM · 578784100 · shares: $9,996,400
- INVENTIVA SA · ADS · 46124U107 · shares: $9,204,300
- ADLAI NORTYE LTD · SPONSORED ADS · 00704R109 · shares: $8,796,074
Reported holdings
43 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 7,350,000 shares | $50,862,000 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 7,200,000 shares | $33,624,000 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 865,000 shares | $33,475,500 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 500,000 shares | $19,480,000 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 970,000 shares | $18,148,700 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | — | 3,700,000 shares | $17,945,000 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 290,000 shares | $11,782,700 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 335,000 shares | $9,996,400 |
| INVENTIVA SA | ADS | 46124U107 | — | 2,435,000 shares | $9,204,300 |
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | — | 764,876 shares | $8,796,074 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 160,000 shares | $8,120,000 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | CALL | 183,000 shares | $6,357,420 |
| PALISADE BIO INC | COM | 696389402 | — | 3,000,000 shares | $6,270,000 |
| BIOAGE LABS INC | COM | 09077V100 | CALL | 250,000 shares | $6,127,500 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 3,000,000 shares | $6,090,000 |
| ADAGENE INC | ADS | 005329107 | — | 1,250,000 shares | $5,250,000 |
| FORTE BIOSCIENCES INC | COM NEW | 34962G208 | — | 225,000 shares | $4,781,250 |
| REZOLUTE INC | COM NEW | 76200L309 | CALL | 900,000 shares | $4,680,000 |
| INFLARX NV | COM | N44821101 | — | 2,000,000 shares | $4,480,000 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 160,000 shares | $4,396,800 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | CALL | 305,000 shares | $4,315,750 |
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | — | 324,977 shares | $4,276,697 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 260,000 shares | $4,261,400 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 300,000 shares | $4,245,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 85,000 shares | $3,998,400 |
| SOL-GEL TECHNOLOGIES LTD | SHS NEW | M8694L137 | — | 52,000 shares | $3,855,280 |
| BIOAGE LABS INC | COM | 09077V100 | — | 155,000 shares | $3,799,050 |
| SCYNEXIS INC | COM | 811292309 | — | 756,884 shares | $3,080,518 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 1,511,496 shares | $2,811,383 |
| DISC MEDICINE INC | COM | 254604101 | CALL | 30,000 shares | $2,194,200 |
| REZOLUTE INC | COM NEW | 76200L309 | — | 403,410 shares | $2,097,732 |
| LIPOCINE INC NEW | COM NEW | 53630X203 | — | 810,000 shares | $2,073,600 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | CALL | 426,000 shares | $2,066,100 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | CALL | 400,000 shares | $1,868,000 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | CALL | 55,000 shares | $1,836,450 |
| CUE BIOPHARMA INC | COM | 22978P205 | — | 50,000 shares | $1,578,000 |
| CALCIMEDICA INC | COM NEW | 38942Q202 | — | 1,244,864 shares | $1,282,210 |
| QUINCE THERAPEUTICS INC | COM | 22053A305 | — | 40,375 shares | $734,421 |
| NUVECTIS PHARMA INC | COM | 67080T108 | CALL | 38,700 shares | $711,693 |
| PASITHEA THERAPEUTICS CORP | COM NEW | 70261F202 | — | 1,000,000 shares | $515,400 |
| INMED PHARMACEUTICALS INC | COM NEW | 457637700 | — | 325,000 shares | $503,750 |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | — | 100,000 shares | $170,000 |
| NEXTCURE INC | COM NEW | 65343E207 | — | 64,464 shares | $103,142 |